The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

Item
http://www.wikidata.org/entity/Q34397232
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.Clinically significant pharmacokinetic interactions between dietary caffeine and medications.Caffeine metabolism in patients with chronic liver disease.Caffeine promotes global spatial processing in habitual and non-habitual caffeine consumers.A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child-Pugh Classification.The role of salivary caffeine clearance in the diagnosis of chronic liver disease.Effects of liver disease on the disposition of the opioid antagonist nalmefene.Serum metabolite/caffeine ratios as a test for liver function.Caffeine alters emotion and emotional responses in low habitual caffeine consumers.Caffeine and theanine exert opposite effects on attention under emotional arousal.Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeine.
P2860

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

Item
http://www.wikidata.org/entity/Q34397232
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@ast
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@en
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@nl
type
label
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@ast
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@en
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@nl
prefLabel
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@ast
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@en
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The pharmacokinetics of caffei ...... ts with chronic liver disease.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.1989.TB05352.X
P407
P433
P478
P577
P5875
P698
P932